The value of RSI of Syneos Health's share price is above 70 as of 5th of January 2025. This usually implies that the stock is becoming overbought or overvalued. The idea behind Relative Strength Index (RSI) is that it helps to track how fast people are
Technical stocks chart with latest price quote for Syneos Health Inc, with technical analysis, latest news, and opinions.
Get the latest Syneos Health Inc. (SYNH) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.
Syneos Health Closes Transaction with Private Investment Firms Yahoo Finance Neutral 2023-09-26 Civitas Resources Set to Join S&P MidCap 400; Hayward Holdings to Join S&P SmallCap 600 Yahoo Finance Neutral 2023-09-26 How Does Syneos Health Inc (SYNH) Stock Rank on Wall Street Tuesday?
The purchase price represents a 24% premium to Syneos Health’s unaffected closing stock price on February 13, 2023, the last trading day prior to media speculation regarding the Company. “This agreement is the culmination of a comprehensive review of opportunities available to Sy...
Syneos Health Inc(SYNH) 42.98+0.01(+0.02%)09/28/23[NASDAQ] Analyst Ratingsfor Wed, Sep 27th, 2023 Help Analyst Target Prices HIGH TARGET MEAN TARGET LOW TARGET 52 WK High 52 WK Low Average Analyst Ratings 3 Mths Ago Hold 3.00
The stock has a fifty day simple moving average of $129.54 and a two-hundred day simple moving average of $131.23. The company has a current ratio of 1.14, a quick ratio of 1.14 and a debt-to-equity ratio of 1.20. The firm has a market cap of $105.29 billion, a price-to-earnings...
Syneos Health, the only fully integrated biopharmaceutical solutions organization, reported financial results for the three and twelve months ended December 31, 2020.
a stable cro with a strategic covid-19 plan jul. 20, 2020 11:10 am et syneos health, inc. (synh) stock 2 comments 3 likes contra biotech review 1.96k follower s follow summary syneos health inc. is a 22-year-old global biopharmaceutical solutions organization offering a full suite ...
In addition, Syneos Health entered into an agreement with the Selling Stockholders to repurchase an aggregate of 600,000 shares of common stock from such Selling Stockholders in a private transaction, concurrently with the closing of the Offering, at the price at which the shares of comm...